Could a poop transplant ease debilitating diarrhea?

NCT ID NCT06333795

Summary

This small pilot study is testing whether a fecal microbiota transplant (FMT), which transfers healthy gut bacteria from a donor, is safe and can help reduce chronic diarrhea in people with systemic sclerosis (scleroderma). Twenty participants will be randomly assigned to receive either the real FMT treatment or a placebo, and researchers will track side effects and changes in bowel symptoms. The main goal is to check safety and see if this approach shows promise for easing this difficult symptom.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aarhus University Hospital

    Aarhus, Denmark

Conditions

Explore the condition pages connected to this study.